ACL
AUCLINICAL FPO [ACL]
Healthcare · ASX Small Cap
$2.0400 +1.0%
Updated 26 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -2First seen: 2026-02-25
Score Breakdown
Technical65
Catalyst51
Sentiment50
Fundamental73
Momentum41
Risk Gate36
Get alerts when ACL's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- Cash positive / operating cashflow positive
- Low P/S ratio (0.5x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (6% of range)
- Elevated short interest (5.7%)
- Earnings in sharp decline (-52% QoQ)
- CANSLIM I: Institutional ownership (84%)
- Sentiment is mixed — no strong consensus either way
- Altman Z-Score grey zone (2.33, low-confidence approx)
- Days to cover very high (17.6)
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Post-earnings drift: negative surprise (SUE -10)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-1.35%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about ACL
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Update - Notification of buy-back - ACL
NONE Notification of cessation of securities - ACL
NONE Update - Notification of buy-back - ACL
Recent ASX Announcements
| 2026-03-25 | Update - Notification of buy-back - ACL |
| 2026-03-25 | Notification of cessation of securities - ACL |
| 2026-03-24 | Update - Notification of buy-back - ACL |
| 2026-03-23 | Update - Notification of buy-back - ACL |
| 2026-03-23 | Notification of cessation of securities - ACL |
Key Metrics
$383.3M
Market Cap
615K
Avg Volume
1.8x
Vol Ratio
$1.94 — $3.24
52-Week Range
5.7%
Short Interest
N/A
Cash Runway
16.7%
ROE
3.6%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: -52% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 92% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | pass | Inst: 84% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #74 of 117 · Sector avg: 46
View all Healthcare signals →Track ACL and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required